Page last updated: 2024-08-23

methyldopa and Autoimmune Chronic Hepatitis

methyldopa has been researched along with Autoimmune Chronic Hepatitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Andrade, RJ; Björnsson, ES; Lucena, MI; Medina-Caliz, I1
Legkova, KS; Topchy, TB; Volchkova, EA1
Ahrens, W; Bonkovsky, HL; deLemos, AS; Foureau, DM; Jacobs, C; Russo, MW1

Reviews

1 review(s) available for methyldopa and Autoimmune Chronic Hepatitis

ArticleYear
Drug-induced liver injury with autoimmune features.
    Seminars in liver disease, 2014, Volume: 34, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antihypertensive Agents; Autoantibodies; Autoimmunity; Chemical and Drug Induced Liver Injury; Cytokines; Diagnosis, Differential; Drug Hypersensitivity; Female; Hepatitis, Autoimmune; HLA Antigens; Humans; Hydralazine; Hypergammaglobulinemia; Liver; Liver Function Tests; Male; Methyldopa; Minocycline; Nitrofurantoin; Time Factors; Young Adult

2014

Other Studies

2 other study(ies) available for methyldopa and Autoimmune Chronic Hepatitis

ArticleYear
Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
    Hepatology communications, 2022, Volume: 6, Issue:8

    Topics: Adalimumab; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Hepatitis A; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Infliximab; Interferons; Methyldopa; Methylprednisolone; Minocycline; Nitrofurantoin

2022
[COVID-19 as a trigger of autoimmune hepatitis. Case report].
    Terapevticheskii arkhiv, 2022, Feb-15, Volume: 94, Issue:2

    Topics: Adult; Antiviral Agents; COVID-19; Diclofenac; Etanercept; Female; Hepatitis, Autoimmune; Humans; Infliximab; Male; Methyldopa; Minocycline

2022